Critical

Acute radiation syndrome (radiological/nuclear incident)

whole-body irradiation · Critical Care / ICU
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

High-dose whole-body ionising radiation causes a dose-dependent syndrome affecting the haematopoietic, gastrointestinal, and neurovascular systems. Time to onset of vomiting and lymphocyte depletion kinetics estimate dose and prognosis; decontamination and supportive care are central.

Red flags

  • Vomiting within minutes to one hour of exposure (very high dose)
  • Rapid, profound lymphocyte depletion
  • Neurological symptoms/hypotension early (neurovascular syndrome, poor prognosis)
  • Combined radiation and traumatic injury
  • Early erythema (high localised/whole-body dose)

Assessment

Differential diagnosis

  • Localised radiation injury
  • Internal contamination/incorporation
  • Combined radiation-trauma injury
  • Chemical exposure
  • Sepsis from another cause
  • Gastroenteritis

Investigations

  • Time to onset of vomiting (prognostic for dose)
  • Serial absolute lymphocyte counts (depletion kinetics estimate dose)
  • FBC trend (pancytopenia)
  • Radiation survey/dosimetry and contamination screening
  • Cytogenetic dicentric assay (biodosimetry)
  • Assess for internal contamination (nasal/wound swabs, bioassay)

Management

  • Ensure responder safety and perform radiological survey; external irradiation alone does not make the patient a hazard, but contamination does
  • Treat life-threatening traumatic injuries first (combined injury worsens prognosis)
  • Decontaminate: remove clothing (removes most contamination) and wash skin; manage contaminated wounds
  • Record the time of onset of nausea and vomiting as a prognostic marker of dose
  • Obtain serial lymphocyte counts to estimate absorbed dose and triage
  • Provide antiemetics and supportive care for the prodromal phase
  • For internal contamination, give specific decorporation agents (e.g. Prussian blue for caesium, DTPA for transuranics, potassium iodide for radioiodine if indicated and timely)
  • Manage the haematopoietic syndrome: neutropenic precautions, growth factors (G-CSF), transfusion support, and treat infections aggressively
  • Manage the gastrointestinal syndrome: fluid and electrolyte support, nutrition, and infection control for high doses
  • Recognise the neurovascular syndrome (very high doses) as generally fatal and provide palliative care
  • Coordinate with radiation safety, haematology, and national radiation emergency services
  • Plan for mass-casualty triage using dose estimates and resource availability

Drugs & doses

Filgrastim (G-CSF) 5-10 mcg/kg SC daily for the haematopoietic syndrome
Prussian blue 3 g PO three times daily for caesium internal contamination
DTPA (zinc/calcium) IV for transuranic (plutonium/americium) contamination
Potassium iodide 130 mg PO (adult) for radioiodine if indicated and early
Antiemetic (ondansetron 8 mg IV)

Disposition

ICU/haematology with reverse isolation for significant doses; national radiation emergency and radiation safety coordination; mass-casualty triage by estimated dose.

Complications & pitfalls

  • Bone marrow failure with infection and haemorrhage
  • Gastrointestinal mucosal breakdown and sepsis
  • Fatal neurovascular syndrome at very high doses
  • Delayed multi-organ and fibrotic effects
  • Combined-injury synergy increasing mortality

Exam pearls

  • Removing clothing eliminates the majority of external contamination
  • Earlier vomiting and faster lymphocyte fall both predict a higher dose and worse prognosis
  • An externally irradiated (non-contaminated) patient is not radioactive and poses no risk to staff
  • Treat trauma first: combined injury markedly worsens radiation outcomes

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.